Coherus Oncology, Inc.CHRSNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank85
Studio
Year-over-Year Change

Net other income and expenses outside core operations

Latest
$-3.59M
↓ 136% vs avg
Percentile
P85
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-1.52M
Historical baseline
PeriodValueYoY Change
TTM$-3.59M-102.6%
2024$140.17M+499.7%
2023$-35.07M-0.6%
2022$-34.87M-50.0%
2021$-23.24M-12.8%
2020$-20.61M-37.5%
2019$-14.99M-200.3%
2018$-4.99M+18.8%
2017$-6.15M+48.1%
2016$-11.86M-